CDC20 and breast cancer: As a result, there were nearly 2.1% (CDC20, CDK1), 1.2% (RRM2), 0.9% (BUB1B), 0.8% (CCNA2), 0.7% (CCNB2) of breast cancer samples included in cBioPortal had genetic changes.